Patents by Inventor Mohamed Kheir Diab

Mohamed Kheir Diab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190150856
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Application
    Filed: September 12, 2018
    Publication date: May 23, 2019
    Inventors: Massi Joe E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Patent number: 10092249
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: October 9, 2018
    Assignee: Masimo Corporation
    Inventors: Massi Joe E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Publication number: 20150272514
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Application
    Filed: March 30, 2015
    Publication date: October 1, 2015
    Inventors: Massi Joseph E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Patent number: 8996085
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: March 31, 2015
    Assignee: Masimo Corporation
    Inventors: Massi Joseph E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Publication number: 20140288400
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like.
    Type: Application
    Filed: June 3, 2014
    Publication date: September 25, 2014
    Applicant: MASIMO Corporation
    Inventors: Mohamed Kheir Diab, Massi Joe E. Kiana, Charles Robert Ragsdale, James M. Lepper
  • Patent number: 8781543
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: July 15, 2014
    Assignee: JPMorgan Chase Bank, National Association
    Inventors: Mohamed Kheir Diab, Massi E. Kiani, Charles Robert Ragsdale, James M. Lepper, Jr.
  • Publication number: 20120184832
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like.
    Type: Application
    Filed: March 26, 2012
    Publication date: July 19, 2012
    Applicant: MASIMO CORPORATION
    Inventors: Mohamed Kheir Diab, Esmaiel Kiani-Azarbayjany, Charles Robert Ragsdale, James M. Lepper, JR.
  • Patent number: 8145287
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like. In one preferred embodiment, coding resistors could be provided across the light sources to allow additional information about the probe to be coded without added leads. However, any device could be used without it being used in parallel.
    Type: Grant
    Filed: April 24, 2009
    Date of Patent: March 27, 2012
    Assignee: Masimo Corporation
    Inventors: Mohamed Kheir Diab, Massi E. Kiani, Charles Robert Ragsdale, James M. Lepper, Jr.
  • Publication number: 20110241869
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Application
    Filed: June 14, 2011
    Publication date: October 6, 2011
    Inventors: Massi Joseph E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Patent number: 7962188
    Abstract: A robust alarm system has an alarm controller adapted to input an alarm trigger and to generate at least one alarm drive signal in response. Alarm subsystems input the alarm drive signal and activate one or more of multiple alarms accordingly. A subsystem function signal provides feedback to the alarm controller as to alarm subsystem integrity. A malfunction indicator is output from the alarm controller in response to a failure within the alarm subsystems.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: June 14, 2011
    Assignee: Masimo Corporation
    Inventors: Massi Joseph E. Kiani, Mohamed Kheir Diab, Marcelo M. Lamego
  • Publication number: 20090270703
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like. In one preferred embodiment, coding resistors could be provided across the light sources to allow additional information about the probe to be coded without added leads. However, any device could be used without it being used in parallel.
    Type: Application
    Filed: April 24, 2009
    Publication date: October 29, 2009
    Applicant: Masimo Corporation
    Inventors: Mohamed Kheir Diab, Massi E. Kiani, Charles Robert Ragsdale, James M. Lepper, JR.
  • Patent number: 7530942
    Abstract: An infant is illuminated with heater radiant energy so as to warm the infant. A detector remotely senses infant radiated energy so as to determine the extent of infant warmth, and a controller responsive to the detector regulates the heater radiant energy accordingly. Skin-reflected heater radiant energy is limited at least during measurements of infant radiated energy.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: May 12, 2009
    Assignee: Masimo Corporation
    Inventor: Mohamed Kheir Diab
  • Patent number: 7526328
    Abstract: Embodiments of the present disclosure include an optical probe capable of communicating identification information to a patient monitor in addition to signals indicative of intensities of light after attenuation by body tissue. The identification information may indicate operating wavelengths of light sources, indicate a type of probe, such as, for example, that the probe is an adult probe, a pediatric probe, a neonatal probe, a disposable probe, a reusable probe, or the like. The information could also be utilized for security purposes, such as, for example, to ensure that the probe is configured properly for the oximeter, to indicate that the probe is from an authorized supplier, or the like. In one preferred embodiment, coding resistors could be provided across the light sources to allow additional information about the probe to be coded without added leads. However, any device could be used without it being used in parallel.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: April 28, 2009
    Assignee: Masimo Corporation
    Inventors: Mohamed Kheir Diab, Massi E. Kiani, Charles Robert Ragsdale, James M. Lepper, Jr.
  • Patent number: 7496391
    Abstract: Embodiments of the present disclosure include an oximeter sensor system including a reusable portion including a substantially rigid connector connected to an end of a cable. The substantially rigid connector includes an electronic element housing at least one electronic component of a probe. The system also includes a disposable portion including a flexible wrap comprising a substantially rigid connection port shaped to receive the substantially rigid connector in a releasably securable manner.
    Type: Grant
    Filed: January 13, 2004
    Date of Patent: February 24, 2009
    Assignee: Masimo Corporation
    Inventors: Mohamed Kheir Diab, Massi E. Kiani, Charles Robert Ragsdale, James M. Lepper, Jr.
  • Patent number: 7280858
    Abstract: A pulse oximetry sensor has an emitter adapted to transmit optical radiation of at least two wavelengths into a tissue site and a detector adapted to receive optical radiation from the emitter after tissue site absorption. A tape assembly is adapted to attach the emitter and detector to the tissue site. A flexible housing is disposed around and optically shields the detector.
    Type: Grant
    Filed: January 4, 2005
    Date of Patent: October 9, 2007
    Assignee: Masimo Corporation
    Inventors: Ammar Al-Ali, Mohamed Kheir Diab, Ronald Coverston, Garrick Maurer, John Schmidt, Chris Schulz
  • Patent number: 7239905
    Abstract: A blood constituent monitoring method for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
    Type: Grant
    Filed: August 16, 2005
    Date of Patent: July 3, 2007
    Assignee: Masimo Laboratories, Inc.
    Inventors: Esmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper, Jr.
  • Patent number: 6931268
    Abstract: A blood glucose monitoring system is disclosed which provides for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
    Type: Grant
    Filed: November 6, 2000
    Date of Patent: August 16, 2005
    Assignee: Masimo Laboratories, Inc.
    Inventors: Esmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper Jr.
  • Patent number: 6826419
    Abstract: A signal processor which acquires a first signal, including a first desired signal portion and a first undesired signal portion, and a second signal, including a second desired signal portion and a second undesired signal portion, wherein the first and second desired signal portions are correlated. The signals may be acquired by propagating energy through a medium and measuring an attenuated signal after transmission or reflection. Alternatively, the signals may be acquired by measuring energy generated by the medium. A processor of the present invention generates a noise reference signal that is a combination of the undesired signal portions and is correlated to both the first and second undesired signal portions. The noise reference signal is then used to remove the undesired portion of each of the first and second measured signals.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: November 30, 2004
    Assignee: Masimo Corporation
    Inventors: Mohamed Kheir Diab, Esmaiel Kiani-Azarbayjany
  • Patent number: RE42753
    Abstract: A blood constituent monitoring method for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: September 27, 2011
    Assignee: MASIMO Laboratories, Inc.
    Inventors: Esmaiel Kiani-Azarbayjany, Mohamed Kheir Diab, James M. Lepper, Jr.
  • Patent number: RE44875
    Abstract: A blood constituent monitoring method for inducing an active pulse in the blood volume of a patient. The induction of an active pulse results in a cyclic, and periodic change in the flow of blood through a fleshy medium under test. By actively inducing a change of the blood volume, modulation of the volume of blood can be obtained to provide a greater signal to noise ratio. This allows for the detection of constituents in blood at concentration levels below those previously detectable in a non-invasive system. Radiation which passes through the fleshy medium is detected by a detector which generates a signal indicative of the intensity of the detected radiation. Signal processing is performed on the electrical signal to isolate those optical characteristics of the electrical signal due to the optical characteristics of the blood.
    Type: Grant
    Filed: March 14, 2011
    Date of Patent: April 29, 2014
    Assignee: Cercacor Laboratories, Inc.
    Inventors: Massi Joe E. Kiani, Mohamed Kheir Diab, James M. Lepper, Jr.